Revvity, 3311-0010, GSP Neonatal Creatine Kinase -MM kit

Overview
This assay measures muscle specific creatine kinase in dried blood spots, helping to detect newborns affected by Duchenne Muscular Dystrophy.
Revvity's GSP® Neonatal Creatine Kinase –MM kit is an immunoassay for measuring CK-MM in dried blood spot samples of newborn babies. As the assay measures the muscle specific isoform, it enables the screening process to find the babies affected by DMD. The kit is available on Revvity's GSP® instrument, a fully automated, high throughput biochemical analyzer.
Benefits of the assay:

The first CE-IVD kit for Duchenne Muscular Dystrophy screening
Fully automated – no reagent preparation
High sensitivity and specificity – good separation between affected and unaffected cases
Wide measuring range enabling numerical result also from most of the non-affected cases
Kit includes reagents, QC material and specific QC certificates
Robust and reliable DELFIA® platform performance Application-Newborn Screening
Brand-GSP®
Detection Modality-Enzymatic
Disorders-Duchenne Muscular Dystrophy
Instrument Compatibility-GSP
Quantity-500 tests
Regulatory Status-CE-IVD marked
Sample Type-Dried blood spots
Technology-Enzymatic
Unit Size-1 kit